Jean-Baptiste Nousbaum

Author PubWeight™ 17.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 2005 1.14
2 Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol 2005 1.08
3 Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 2003 1.05
4 Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J Med Virol 2009 1.02
5 Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol 2005 0.93
6 Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol 2007 0.89
7 Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. Gastroenterol Clin Biol 2004 0.88
8 Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients. World J Hepatol 2013 0.85
9 Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol 2006 0.82
10 Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients. J Hepatol 2003 0.80
11 Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Med Genet 2005 0.80
12 Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol 2002 0.80
13 Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis 2012 0.80
14 Epidemiology of hepatocellular carcinoma in Finistère. Prospective study from June 2002 to May 2003. Gastroenterol Clin Biol 2007 0.79
15 Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 2009 0.79
16 Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infect Genet Evol 2011 0.79
17 [Is there still a need for liver biopsy in chronic hepatitis C?]. Gastroenterol Clin Biol 2002 0.78
18 [Current trends in liver biopsy indications in chronic liver diseases]. Presse Med 2012 0.78
19 Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study. PLoS One 2013 0.78
20 Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival. Pancreas 2016 0.77
21 Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003. Eur J Gastroenterol Hepatol 2010 0.77
22 [Are reagent strips useful for the diagnosis of spontaneous bacterial peritonitis?]. Gastroenterol Clin Biol 2006 0.76
23 Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors. Eur J Gastroenterol Hepatol 2016 0.76
24 Benefit of antibiotic prophylaxis in cirrhotic patients with gastrointestinal bleeding in real life. Eur J Gastroenterol Hepatol 2015 0.75
25 Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol 2017 0.75
26 HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients. Ann Hematol 2015 0.75
27 Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France. Eur J Gastroenterol Hepatol 2016 0.75
28 Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol 2017 0.75